Literature DB >> 9761309

In utero irradiation of rats as a model of human cerebrocortical dysgenesis: a review.

S N Roper1.   

Abstract

Certain developmental abnormalities of the cerebral cortex are closely associated with epilepsy in humans. Exposure of fetal rats to external gamma-irradiation produces diffuse cortical dysplasia and neuronal heterotopia. These abnormalities are the result of radiation-induced cell death coupled with continued cortical development in an altered cellular environment. In vivo electroencephalography studies in these animals have revealed an increased propensity for electrographic seizures in the presence of the sedating agents, acepromazine and xylazine. In vitro neocortical slices containing dysplastic cortex demonstrate enhanced excitability, as compared to control neocortex, when inhibition that is mediated by the A-type gamma-amino butyric acid receptor is blocked with bicuculline methiodide. In utero irradiation of rats produces structural changes that mimic some aspects of cerebral dysgenesis in humans and results in physiologic changes that increase the animals' propensity for seizures. Similarities and differences between the animal model and the human syndromes are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761309     DOI: 10.1016/s0920-1211(98)00040-0

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  16 in total

1.  Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia.

Authors:  Mercedes Paredes; Samuel J Pleasure; Scott C Baraban
Journal:  J Comp Neurol       Date:  2006-03-01       Impact factor: 3.215

2.  REORGANIZATION OF BARREL CIRCUITS LEADS TO THALAMICALLY-EVOKED CORTICAL EPILEPTIFORM ACTIVITY.

Authors:  Qian-Quan Sun; John R Huguenard; David A Prince
Journal:  Thalamus Relat Syst       Date:  2005-12

3.  Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia.

Authors:  Susan L Campbell; John J Hablitz
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

4.  Targeted disruption of layer 4 during development increases GABAA receptor neurotransmission in the neocortex.

Authors:  J Abbah; Maria F M Braga; S L Juliano
Journal:  J Neurophysiol       Date:  2013-10-23       Impact factor: 2.714

5.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

6.  Influence of the embryonic preplate on the organization of the cerebral cortex: a targeted ablation model.

Authors:  Y Xie; E Skinner; C Landry; V Handley; V Schonmann; E Jacobs; R Fisher; A Campagnoni
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 7.  Novel animal models of pediatric epilepsy.

Authors:  Stéphane Auvin; Eduardo Pineda; Don Shin; Pierre Gressens; Andrey Mazarati
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

8.  Focal cortical dysplasia with calcification: a case report.

Authors:  Kazuhiro Samura; Takato Morioka; Fumiaki Yoshida; Kimiaki Hashiguchi; Yasushi Miyagi; Masahiro Mizoguchi; Tadahisa Shono; Shinji Nagata; Satoshi O Suzuki; Tomio Sasaki
Journal:  Childs Nerv Syst       Date:  2007-12-22       Impact factor: 1.475

9.  Balance of inhibitory and excitatory synaptic activity is altered in fast-spiking interneurons in experimental cortical dysplasia.

Authors:  Fu-Wen Zhou; Huan-Xin Chen; Steven N Roper
Journal:  J Neurophysiol       Date:  2009-08-19       Impact factor: 2.714

10.  Upregulation of glutamate receptors in rat cerebral cortex with neuronal migration disorders.

Authors:  Min-Cheol Lee; Jae-Jin Shim; Jae-Hyoo Kim; Myeong-Kyu Kim; Young-Jong Woo; Woong-Ki Chung; Jung-Jin Suh; Sang-Chae Nam; Ji-Shin Lee; Yeong-Seon Kim; Jin-Hee Kim; Hyoung-Ihl Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.